UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 250

Sortiert nach

European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

European urology, 2022-01, Vol.81 (1), p.75-94

2022

Volltextzugriff (PDF)

A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort

Scientific reports, 2018-02, Vol.8 (1), p.3737-12, Article 3737

2018

Volltextzugriff (PDF)

A Molecular Taxonomy for Urothelial Carcinoma

Clinical cancer research, 2012-06, Vol.18 (12), p.3377-3386

2012

Volltextzugriff (PDF)

Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid. In press. https://doi.org/10.1056/EVIDoa2200092

European urology open science (Online), 2022-12, Vol.46, p.53-54

2022

Volltextzugriff (PDF)

Toward a Molecular Pathologic Classification of Urothelial Carcinoma

The American journal of pathology, 2013-09, Vol.183 (3), p.681-691

2013

Volltextzugriff (PDF)

Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma

PloS one, 2012-06, Vol.7 (6), p.e38863-e38863

2012

Volltextzugriff (PDF)

Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and Outcome

Cancer research (Chicago, Ill.), 2010-05, Vol.70 (9), p.3463-3472

2010

Volltextzugriff (PDF)

Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review

Cancers, 2022-04, Vol.14 (9), p.2062

2022

Volltextzugriff (PDF)

Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis

PloS one, 2020-11, Vol.15 (11), p.e0241711-e0241711

2020

Volltextzugriff (PDF)

Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer-A Narrative Review

Cancers, 2022-03, Vol.14 (7), p.1692

2022

Volltextzugriff (PDF)

MiRNA expression in urothelial carcinomas: Important roles of miR‐10a, miR‐222, miR‐125b, miR‐7 and miR‐452 for tumor stage and metastasis, and frequent homozygous losses of miR‐31

International journal of cancer, 2009-05, Vol.124 (9), p.2236-2242

2009

Volltextzugriff (PDF)

Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: A nation-wide population-based study

PloS one, 2021, Vol.16 (2), p.e0246703-e0246703

2021

Volltextzugriff (PDF)

Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer

PloS one, 2022, Vol.17 (9), p.e0274859-e0274859

2022

Volltextzugriff (PDF)

Molecular subtype classification of urothelial carcinoma in Lynch syndrome

Molecular oncology, 2018-08, Vol.12 (8), p.1286-1295

2018

Volltextzugriff (PDF)

Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors

Urologic oncology, 2014-08, Vol.32 (6), p.791-797

2014

Volltextzugriff (PDF)

A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1

PloS one, 2011-04, Vol.6 (4), p.e18583-e18583

2011

Volltextzugriff (PDF)

Re: Longer is Better for Endoscopic Follow-up of Upper Tract Urothelial Carcinoma After Ureteroscopic Treatment: An Evaluation Spanning 10 Years of Data

European urology, 2024-04, Vol.85 (4), p.392-392

2024

Volltextzugriff (PDF)

No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study

World journal of urology, 2020, Vol.38 (2), p.381-388

2020

Volltextzugriff (PDF)

The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies

European journal of epidemiology, 2021-08, Vol.36 (8), p.781-792

2021

Volltextzugriff (PDF)

Adjuvant checkpoint inhibition after cystectomy - why, when, and for whom?

Scandinavian journal of urology, 2022-01, Vol.56 (1), p.73-74

Liedberg, Fredrik

2022

Volltextzugriff (PDF)

Perioperative management of upper tract urothelial carcinoma in the Nordic countries

BMC urology, 2024-06, Vol.24 (1), p.1-8, Article 132

2024

Volltextzugriff (PDF)

Personalized medicine for bladder cancer

Scandinavian journal of urology, 2021-09, Vol.55 (5), p.419-419

Liedberg, Fredrik

2021

Volltextzugriff (PDF)

Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship

Scientific reports, 2020-11, Vol.10 (1), p.19539-19539, Article 19539

2020

Volltextzugriff (PDF)

Re: Laura S. Mertens, Richard P. Meijer, J. Alfred Witjes. Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.017

European urology, 2023-03, Vol.83 (3), p.e82-e83

2023

Volltextzugriff (PDF)

Latent heterogeneity of muscle‐invasive bladder cancer in patient characteristics and survival: A population‐based nation‐wide study in the Bladder Cancer Data Base Sweden (BladderBaSe)

Cancer medicine (Malden, MA), 2023-06, Vol.12 (12), p.13856-13864

2023

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(203)

Publikationsform

Artikel
(249)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(178)
Science & Technology
(171)
Medical And Health Sciences
(168)
Klinisk Medicin
(164)
Clinical Medicine
(162)
Life Sciences & Biomedicine
(156)
Humans
(137)
Urologi Och Njurmedicin
(116)
Urology And Nephrology
(115)
Urology & Nephrology
(111)
Bladder Cancer
(96)
Cancer Och Onkologi
(89)
Cancer And Oncology
(88)
Male
(79)
Female
(67)
Aged
(58)
Urinary Bladder Neoplasms - Pathology
(56)
Middle Aged
(43)
Urinary Bladder Neoplasms - Surgery
(43)
Oncology
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort

A Molecular Taxonomy for Urothelial Carcinoma

Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid. In press. https://doi.org/10.1056/EVIDoa2200092

Toward a Molecular Pathologic Classification of Urothelial Carcinoma

Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma

Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and Outcome

Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review

Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis

Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer-A Narrative Review

MiRNA expression in urothelial carcinomas: Important roles of miR‐10a, miR‐222, miR‐125b, miR‐7 and miR‐452 for tumor stage and metastasis, and frequent homozygous losses of miR‐31

Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: A nation-wide population-based study

Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer

Molecular subtype classification of urothelial carcinoma in Lynch syndrome

Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors

A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1

Re: Longer is Better for Endoscopic Follow-up of Upper Tract Urothelial Carcinoma After Ureteroscopic Treatment: An Evaluation Spanning 10 Years of Data

No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study

The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies

Adjuvant checkpoint inhibition after cystectomy - why, when, and for whom?

Perioperative management of upper tract urothelial carcinoma in the Nordic countries

Personalized medicine for bladder cancer

Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship

Re: Laura S. Mertens, Richard P. Meijer, J. Alfred Witjes. Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.017

Latent heterogeneity of muscle‐invasive bladder cancer in patient characteristics and survival: A population‐based nation‐wide study in the Bladder Cancer Data Base Sweden (BladderBaSe)

Aktive Filter

Suchergebnisse filtern